Abstract Although the role of rising atmospheric carbon dioxide concentration [CO 2 ] on plant growth and fecundity is widely acknowledged as important within the scientific community; less research is available regarding the impact of [CO 2 ] on secondary plant compounds, even though such compounds can play a significant role in human health. At present, Artemisia annua, an annual plant species native to China, is widely recognized as the primary source of artemesinin used in artemesinin combination therapies or ACTs. ACTs, in turn, are (1983). Overall, these data provide the first evidence that historic and projected increases in atmospheric [CO 2 ] may be associated with global changes in artemesinin chemistry, potentially allowing a greater quantity of drug available for the same area of cultivation.
Introduction
In recent decades, a considerable body of research has investigated the role of projected increases in carbon dioxide concentration [CO 2 ] on numerous aspects of plant biology, with a merited focus on managed systems, e.g., agriculture (Lobell et al. 2011; Porter et al. 2014) . However, qualitative aspects of plant biology are also known to be influenced by increasing [CO 2 ] including changes in the concentration of secondary defensive compounds; including isoprene, terpenes, alkaloids, tannin, flavonol, and / or phenolics (Stiling and Cornelissen 2007; Sun et al. 2011; Zavala et al. 2008 ). In addition to their known physiological function in plant protection, many of these secondary compounds are widely acknowledged as having pharmacological value to the human population. As such, the role of [CO 2 ] on the production of morphine, nicotine, atropine, scopolamine, and hypericin was examined for individual plants under indoor conditions (Stuhlfauth and Fock 1990; Zobayed and Saxena 2004; Ziska et al. 2008) . However, among plant-based pharmacological compounds the influence of atmospheric [CO 2 ] on artemesinin production in situ remains undocumented.
Known historically for more than 2000 years for its medicinal properties (Miller and Su 2011) , artemesinin was isolated by the Chinese government in the early 1970s as the active antimalarial compound of Artemisia annua (qing hao or sweet wormwood), a widelydistributed annual plant species native to temperate Asia (De Ridder et al. 2008) . The World Health Organization (World Health Organization WHO 2003) recommended the use of artemesinin combination therapies (ACTs) as an efficacious means to combat the rising resistance of the malaria parasite Plasmodium falciparum while preserving the efficacy of artemesinin and its derivatives. P. falciparum is recognized as the most dangerous form of malaria with the highest morbidity and mortality (WHO 2003) . Although P. falciparum resistance has been reported in Southeast Asia (Burrows et al. 2013) , plant-based sources are still considered the primary compounds for countering uncomplicated malaria due to Plasmodium falciparum parasites (Fairhurst et al. 2012; Sahr et al. 2013) . Because of its importance in the treatment of malaria, any global environmental change that alters the growth and production of artemesinin by A. annua could have a significant impact on production, costs, and public health consequences (e.g., manufacture of semi-synthetic artemesinin).
To determine if, and to what extent, recent and projected increases in atmospheric [CO 2 ] could alter the concentration of artemesinin, we grew and analyzed wild and cultivated populations of A. annua at ambient and mid-century (2060) projected concentrations of atmospheric CO 2 in situ using free-air CO 2 enrichment (FACE) methods. To confirm, and expand upon these experimental data, we also used an historical approach, assessing 100+ year herbarium samples from 236 locations within mainland China to quantify the relationship between recent increases in [CO 2 ] and artemesinin concentration in A. annua during the 20th century ).
Materials and methods

Experimental site
The study was conducted at the FACE facility located at Zhongcun village (119°42'0^E, 32°35'5^N), Yangzhou city, Jiangsu province (Zhu et al. 2012) . The operation and control systems for the FACE facilities were the same as those used at the Japan FACE site (Zhu et al. 2012) . In brief, three rectangular adjoining fields were used. Within each field, a FACE plot was paired with an ambient control, and plot centers were 90 m apart to avoid movement of additional [CO 2 ] to the ambient plots, (i.e., a total of three replications). Each FACE plot was encircled with an octagonal ring (14 m in diameter) with emission tubes that injected pure CO 2 at 30 cm above the plant canopy. Ambient control plots did not receive any supplemental CO 2 . The CO 2 setpoint in FACE plots was 200 μmol mol , total porosity, 54 %, organic carbon, 18.4 g kg , total available phosphorous, 10.1 mg kg −1 .
Sampling and growth analysis
Sampling and biometrical analysis were determined through destructive sampling during initial anthesis (floral opening), which is correlated with maximum artemesinin concentration (Lei et al. 2011) . The uppermost leaf for four and six plants from each plot and [CO 2 ] treatment were sampled for 2012 and 2013, respectively. Height, main stem diameter, and number of primary branches were recorded for all plants prior to destructive sampling from plant base to tip. Leaves and stems were oven dried then passed through a 5 mm mesh to separate leaf lamina from pedicles, then ground.
Herbarium samples
The herbarium for the Beijing Institute of Botany, the Kunming Institute of Botany and the Jiangsu Institute of Botany coordinated and collected the A. annua samples throughout China (Fig. 2) . These samples were screened so that only leaves adjacent to floral structures were sampled. This allowed temporal consistency in regard to development stage and reflects the time of maximum artemesinin concentration.
Biochemistry
Nitrogen and carbon within leaf tissue were determined using an elemental analyzer (PE 2400, Series II CHNS/O, U.S.). Leaf isotopic 13 C composition was determined using an elemental analyzer coupled to a 20/20 isotope ratio mass spectrometer (IRMS) SerCon 20-22, Crewe, UK, using international PDB standard (Craig 1957) . Foliar artemesinin was extracted using the method of Pu et al. (2009) with minor modifications. 100 mg samples of dried leaves were extracted using 20 ml of boiling petroleum ether in an ultrasonic bath for 30 min. The supernatant was evaporated to dryness and re-dissolved with 5 ml pure methanol. Samples (1 ml) were then incubated with 4 ml of 0.2 % NaOH at 48°C for 30 min. The mixture was allowed to come to room temperature, followed by 5 ml wash with 0.08 M acetic acid. After filtering with a 0.45 μm nylon filter, a 20 μl aliquot of the reaction products was injected into a C-18 column (Sunfine Tm C18, 250×4.6 mm) for HPLC, attached to a 2998 Photo-Diode Array. Isocratic elution was carried out with 50 % methanol (diluted with 0.01 M phosphate buffer, pH 7.0) as the mobile phase, at a flow rate of 1 ml min ) by leaf biomass (g).
Statistics
The field experiment was a completely randomized design with three replicates. To test for significant differences, analysis of variance (ANOVA) with [CO 2 ] as the main plot, species as subplots, and stage of growth as a split plot were used. A linear correlation and coefficient of determination (r 2 ) were also calculated for artemesinin concentration for the [CO 2 ] value from the year that the herbarium sample was taken. Statistical calculations were carried out using SPSS statistical software (SPSS 19.0, SPSS Inc., USA).
Results
The age of A. annua samples obtained in this study is reflected in part, by the observed change in their isotopic C 13 content (Fig. 1) . This, in turn, reflects atmospheric dilutions in the amount of available C 13 due to the burning of fossil fuels during the 20th century (Nozaki et al. 1978) . Because the concentration of artemesinin varies with A. annua development, we quantified the artemesinin concentration during the early stage of floral opening or anthesis (i.e., time of maximum artemesinin concentration) as a function of [CO 2 ] induced increases in C:N for wild A. annua populations (Fig. 2) . Validation tests of the relationship were conducted for in situ southwestern Chinese populations of wild A. annua (closed circles in Fig. 2 ) at the same growth stage. Overall, these data indicated that the relationship between C:N and artemesinin concentration was robust and significant (R=0.86, P<0.001).
To determine the historical (20th century) change in artemesinin concentration, herbarium leaf samples from 236 locations throughout China over the period 1905 through 2009 (Fig. 3) were used to estimate artemesinin concentrations based on their C:N ratio. These mounted herbarium samples were sampled only if they were collected during the early stage of floral opening, thereby providing for consistent comparisons of stage of growth between the experimental and herbarium data. The estimated change in artemesinin content from historical A. annua samples (Fig. 4a) is directly correlated (R=0.97, P<0.001) to the increase in (Fig. 4b) , e.g., most of the increase in artemesinin concentration is associated with the rapid increase in atmospheric [CO 2 ] since the 1960s.
The FACE facility was also used to estimate growth and artemesinin response of wild and cultivated A. annua to projected, mid-21st century increases in [CO 2 ] (~200 μmol mol −1 above ambient). Overall, increasing [CO 2 ] resulted in significant increases in net photosynthetic rate and increased plant growth (Table 1) . At the projected [CO 2 ] concentration, plant biomass increased, leaf N concentration fell and artemesinin production per plant rose 50-86 %, with slightly greater relative increases observed for the wild A. annua populations (Table 1) .
Discussion
A number of studies have suggested that [CO 2 ] can affect plant-based pharmacopeia (Stiling and Cornelissen 2007; Zavala et al. 2008; Sun et al. 2011) . However a clear association between [CO 2 ]-induced physiological changes and plant-based pharmacological concentration has been unavailable at the field level. Quantifying 20th century increases in atmospheric [CO 2 ] on artemesinin content over a large geographical region may be especially crucial in determining its regional availability and potential efficacy as an antimalarial treatment. The current data indicate that both recent (during the 20th century) and projected increases (ca 2060) in atmospheric [CO 2 ] are associated with concomitant increases in the intensification of artemesinin production. As such, the use of CO 2 to grow A. annua commercially (e.g., greenhouses) as a means to enhance artemesinin concentration has obvious and immediate value in regard to production of either wild or cultivated A. annua. Clarification, however, in regard to artemesinin concentration limits associated with additional [CO 2 ] and intraspecific variation in the [CO 2 ] response among cultivated and wild type A. annua requires further exposition and quantification (Ferreira et al. 2005) . (Osbrink et al. 1987; Rogers et al. 1996; Gifford et al. 2000; Coviella et al. 2002; McMurtrie et al. 2008; Robinson et al. 2012) . The Carbon Nutrient Balance (CNB) hypothesis (Bryant et al. 1983 ) predicts that the production of secondary plant compounds is indicative of the relative availability of carbon and nutrients (e.g., N) relative to the plant growth stage. For example, if N is reduced, carbon-based secondary compounds should increase; conversely, if N increases, an increase in N-based secondary compounds should result.
However, the value of the CNB hypothesis has never been explicitly tested in regard to rising [CO 2 ] and/or secondary plant compounds of known pharmacological importance. Kinney and Lindroth (1997) found that phenolic glycosides did not always increase with elevated [CO 2 ]; whereas it was reported that phenolics and starch increased with exposure to elevated [CO 2 ] (Roth and Lindroth 1995) . Among studied pharmacological compounds, the range of C:N has been narrow. For example, rising [CO 2 ] resulted in a reduction in the concentration of nicotine (C 10 H 14 N 2 ), but no clear affect, or an increase in the concentration of atropine (C 17 H 23 NO 3 ), and scopolamine (C 17 H 21 NO 4 ), respectively (Ziska et al. 2005) . Table S1 Artemesinin is a sesquiterpene lactone containing an unusual endoperoxide bridge; and, unlike other antimalarials, lacks N (C 15 H 22 O 5 ). Interestingly, increasing leaf tissue N from supplemental N fertilization actually decreases leaf artemesinin concentration (Ferreira 2007; Davies et al. 2009) the CNB hypothesis. Such a result was observed in the current study. The increase in C:N and artemesinin content is also consistent with the proposition of Coviella et al. (2002) that the CNB hypothesis is a good predictor under conditions of excess carbon and limiting N and least relevant when N is not limiting. Although there is evidence that, on average, rising [CO 2 ] can increase carbon-based, while simultaneously decreasing N-based, secondary metabolites (Robinson et al. 2012) , we caution that generalizations regarding CNB and the impact of [CO 2 ] on leaf chemistry are difficult to formulate and may be subject to phytohormonal regulation (Ryan et al. 2010; DeLucia et al. 2012) . In addition, interactions between [CO 2 ] and other variables, most notably temperature, are of obvious consequence and deserve heightened scrutiny; in particular as concurrent changes in [CO 2 ] and temperature can amplify decreases in leaf N and substantially increase the C:N (Zvereva and Kozlov 2006) . Consequently any synergism between these parameters could result in further stimulation of artemesinin concentration and production from A. annua.
Malaria remains an historical public health challenge, responsible for the annual deaths of approximately half a million or more people, primarily children under the age of five (WHO 2012) . The spatial distribution and seasonality of malaria is also known to be climate sensitive. Consequently, human-induced climate change is likely to put additional people at risk as the geographic range of malaria increases along the current edges of its latitudinal distribution, as well as increases in the mean altitude of current malarial cases, e.g., tropical highlands (Caminade et al. PNAS, 2014) .
Although recent data indicated a delayed response to ACTs in five countries within the Greater Mekong subregion (Dondorp 2009; Burrows et al. 2013) , there is still clear evidence that plant-sourced artemesinin and its derivatives can inhibit the viability of the protozoan parasites that cause malaria (Sahr et al. 2013) . Consequently, while trials are currently underway to develop novel synthetic single dose anti-malarial treatments (Charman et al. 2011; Burrows et al. 2013 ), ACTs will continue to be among the most effective pharmacological treatments for falciparum malaria (Alonso and Tanner 2013) , which is associated with the greatest occurrence of morbidity and mortality, particularly in sub-Saharan Africa (Sahr et al. 2013) . If, as early evidence suggests, climate change facilitates the spread of P. falciparum malaria, then the short-term temporal effectiveness of ACT treatments will continue to remain a significant priority for the 21st century (Smith et al. 2014) . The current data indicate that [CO 2 ] while not affecting the recommended treatment dose, may improve the production and efficiency of artemesinin at the field level; and, potentially, in the larger context of climate change, where and when A. annua can be grown. Whether [CO 2 ] and/or climate change alter the availability and cost of artemesinin in the context of concurrent changes in the spread of malaria is, at this time, unknown.
Overall, understanding how climate change alters the spread of human infectious disease globally is an immediate and meritorious goal; however, we would argue that it is also imperative to understand how [CO 2 ] and/or climate change will alter the range of plant based medicines used to treat those diseases.
